SinoMab BioScience Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	101.03	61.9	203.66	345.71	562.98	810.37
Short-Term Investments	-	3.89	2.87	46.2	26.55	12.77
Trading Asset Securities	42.06	44.98	30.99	30.48	-	93.06
Cash & Short-Term Investments	143.1	110.77	237.53	422.39	589.53	916.2
Cash Growth	-26.56%	-53.36%	-43.77%	-28.35%	-35.66%	-24.12%
Prepaid Expenses	6.31	8.56	3.22	12.23	6.16	18.15
Other Current Assets	13.88	66	29.44	12.47	-	-
Total Current Assets	163.28	185.34	270.18	447.09	595.69	934.35
Property, Plant & Equipment	541.61	550.72	536.77	485.82	356.21	145.92
Long-Term Investments	-	-	-	-	26.93	31.9
Other Intangible Assets	0.52	0.94	1.84	2.6	1.92	-
Other Long-Term Assets	16.69	16.11	38.99	72.84	60.91	17.35
Total Assets	722.09	753.1	847.79	1,008	1,042	1,130
Accrued Expenses	-	3.07	5.93	11.36	7.85	1.75
Current Portion of Long-Term Debt	105.16	112.64	66.59	30.42	5	5
Current Portion of Leases	12.64	12.94	4.66	15.38	7.39	9.13
Current Unearned Revenue	-	-	0.3	0.3	1.55	1.55
Other Current Liabilities	70.69	74.85	95.17	129.93	76.57	41.38
Total Current Liabilities	188.49	203.5	172.65	187.39	98.36	58.8
Long-Term Debt	249.21	306.65	324.81	238.36	193.78	55.46
Long-Term Leases	41.11	50.04	54.75	73.02	69.29	28.25
Total Liabilities	478.8	560.19	552.2	498.77	361.43	142.51
Common Stock	1,898	1,790	1,725	1,725	1,679	1,679
Retained Earnings	-1,725	-1,675	-1,490	-1,247	-962.96	-674.77
Comprehensive Income & Other	70.15	78.19	60.6	31.48	-35.94	-17.35
Shareholders' Equity	243.29	192.91	295.58	509.58	680.23	987.01
Total Liabilities & Equity	722.09	753.1	847.79	1,008	1,042	1,130
Total Debt	408.11	482.27	450.81	357.18	275.46	97.84
Net Cash (Debt)	-265.02	-371.5	-213.28	65.2	314.07	818.36
Net Cash Growth	-	-	-	-79.24%	-61.62%	-29.07%
Net Cash Per Share	-0.24	-0.35	-0.21	0.07	0.32	0.81
Filing Date Shares Outstanding	1,205	1,092	1,035	1,035	1,006	1,006
Total Common Shares Outstanding	1,205	1,092	1,035	1,035	1,006	1,006
Working Capital	-25.21	-18.16	97.54	259.7	497.32	875.55
Book Value Per Share	0.20	0.18	0.29	0.49	0.68	0.98
Tangible Book Value	242.77	191.98	293.74	506.98	678.31	987.01
Tangible Book Value Per Share	0.20	0.18	0.28	0.49	0.67	0.98
Machinery	-	67.2	66.4	58.61	47.02	20.73
Construction In Progress	-	453.07	419.14	336.16	197.47	74.44
Leasehold Improvements	-	28.48	28.37	33.42	29.81	17.77

Source: S&P Global Market Intelligence. Standard template. Financial Sources.